O. Murillo, I. Grau, J. Lora-Tamayo, J. Gomez-Junyent, A. Ribera, F

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.

Gram-positive infections: lessons learnt and novel solutions

Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects D. Johnsson, P. Mölling,

New epidemiology of Staphylococcus aureus infection in Asia

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood.

G. Cornaglia, A. Lönnroth, M. Struelens

I. López-Hernández, M. Delgado Valverde, N. Batista Díaz, A. Pascual

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Risk factors for metastatic osteoarticular infections after a long follow-up of patients with Staphylococcus aureus bacteraemia A. Lalueza, A. Morales-Cartagena,

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Migrant health—a cause for concern?

J.-P. Van geertruyden Clinical Microbiology and Infection

Detection of Panton–Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects D. Johnsson, P. Mölling,

Clinical impact of antibiotic-resistant Gram-positive pathogens

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.

Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain A. Manzur, A.M. Dominguez, M. Pujol, M.P.M. González,

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Do we need new antibiotics?

A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

Levofloxacin in the treatment of ventilator-associated pneumonia

M. Aires-de-Sousa Clinical Microbiology and Infection

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals E.E. Udo, N. Al-Sweih, B.

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals G.L. Cartolano,

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year.

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

Molecular analysis of community-acquired methicillin-susceptible and resistant Staphylococcus aureus isolates recovered from bacteraemic and osteomyelitis.

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

O. Murillo, A. Roset, B. Sobrino, J. Lora-Tamayo, R. Verdaguer, E

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

W. Witte Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:

J. Segreti Clinical Microbiology and Infection

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century O. Murillo, I. Grau, J. Lora-Tamayo, J. Gomez-Junyent, A. Ribera, F. Tubau, J. Ariza, R. Pallares Clinical Microbiology and Infection Volume 21, Issue 3, Pages 254.e1-254.e8 (March 2015) DOI: 10.1016/j.cmi.2014.09.007 Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 1 Proportion of total bacteraemic cases compared with the total cases and different types of bacteraemic osteaorticular infections. Clinical Microbiology and Infection 2015 21, 254.e1-254.e8DOI: (10.1016/j.cmi.2014.09.007) Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 2 Incidence of the more frequent microorganisms responsible for bacteraemic osteaorticular infections in the study period. (a) Incidence of cases caused by methicillin-susceptible and -resistant Staphylococcus aureus. (b) Incidence of cases caused by Streptococcus sp., Enterococcus sp. and Gram-negative bacilli. Clinical Microbiology and Infection 2015 21, 254.e1-254.e8DOI: (10.1016/j.cmi.2014.09.007) Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions